OCT in Amblyopic Childre

Not Applicable

Completed

• Registration Number: CTRI/2018/04/012942
• Lead Sponsor: Giridhar Eye Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2016-12-11
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

(a) Patients whose difference in visual acuity was at least two lines between the normal and amblyopic eye on the snellen visual acuity charts.

(b) Anisometropia with an interocular difference in refraction( astigmatism >1.5 D,hypermetropia >1 D,myopia >2 D).

(c) The patients with strabismic amblyopia with esotropia /exotropia/hypotropia/hypertropia of the amblyopic eye.

(d) Unilateral amblyopic eyes with best corrected visual acuity of 6/12 or worse, the best corrected visual acuity of the fellow eye of 6/6.

Exclusion Criteria

Patients with

(a) Ocular diseases such as glaucoma, nystagmus ,retinal disorders, or laser treatment, cataract.

(b) Organic eye disease

(c) Refractive errors >6 D

(d) Ocular anomalies

(e) Patients who were too young to cooperate

(f) Patients whose pupillary dilation is not sufficient

(g) Poor fixation

(h) Sensory deprivation amblyopia

(i) History or evidence of intraocular surgery (j) Neurological disease

(k) History of seizures

(l) Prematurity (birth weight < 1500 g or gestational age <34 weeks)

(m) Mental retardation

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Compare the amblyopic eye and the normal eye at the beginning and at 6 monthly after giving appropriate correction and occlusion therapy.Timepoint: 15 months at six monthly intervals.

Secondary Outcome Measures

Name	Time	Method
Analyse the SD-OCT findings at presentation and at six months after giving appropriate correction and oclusion therapy.Timepoint: 15 months at six monthly intervals.